Cervical Dystonia
77
4
4
60
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
20 trials with published results (26%)
Research Maturity
60 completed trials (78% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
2.6%
2 terminated out of 77 trials
96.8%
+10.3% vs benchmark
27%
21 trials in Phase 3/4
33%
20 of 60 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 60 completed trials
Clinical Trials (77)
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Cholinergic Receptor Imaging in Dystonia
Effect of Vibro-tactile Stimulation Intensity on Head Posture in Cervical Dystonia
Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia
Zinc as an Adjunctive Therapy for Cervical Dystonia
Three-dimensional Analysis of Obliquus Capitis Inferior Muscle Function in the Rotatory Form of Cervical Dystonia
Study of the Oral Treatment MTR-601 in Cervical Dystonia
Physiotherapy and Botox for Cervical Dystonia: Impact of Sensory Tricks and Brain Imaging Insights
Propensity to Develop Plasticity in the Parieto-Motor Networks in Dystonia From the Perspective of Abnormal High-Order Motor Processing
Dystonia Treatment With Injections Supplemented By Transcranial Magnetic Stimulation
Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia
Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia
A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia
Long-term Outcome of DBS Versus Botulinum Toxin Treatment in Cervical Dystonia
Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia
Neurotoxin and Physical Therapy
Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia
Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia
Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)
Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex